0001209191-16-131031.txt : 20160705 0001209191-16-131031.hdr.sgml : 20160705 20160705162812 ACCESSION NUMBER: 0001209191-16-131031 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160701 FILED AS OF DATE: 20160705 DATE AS OF CHANGE: 20160705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAPLAN GILLA CENTRAL INDEX KEY: 0001247024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 161750835 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 FORMER NAME: FORMER CONFORMED NAME: KAPLAN GILLA PHD DATE OF NAME CHANGE: 20030625 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-07-01 0 0000816284 CELGENE CORP /DE/ CELG 0001247024 KAPLAN GILLA C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 0 0 0 Common Stock 2016-07-01 4 M 0 733 0.00 A 81852 D Restricted Stock Unit 2016-07-01 4 M 0 733 0.00 D Common Stock 733 734 D One-third of the restricted stock units granted to the reporting person on July 1, 2014 vested and settled for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. The balance of the restricted stock units will vest on July 1, 2017. Vested shares will be delivered to the reporting person promptly after the vesting date. The restricted stock units were issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). /s/Peter N. Kellogg_______________________ Peter N. Kellogg, Attorney-in-Fact 2016-07-05